Adagio Medical Holdings Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Adagio Medical Holdings stock have an average target of 3.50, with a low estimate of 3.00 and a high estimate of 4.00. The average target predicts an increase of 221.10% from the current stock price of 1.09.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$3.50	$4.00	$4.00
Change	+175.23%	+221.10%	+266.97%	+266.97%

Analyst Ratings

The average analyst rating for Adagio Medical Holdings stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1
Buy	0	0	1
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt O'Brien Piper Sandler	Piper Sandler	Buy Initiates $3	Buy	Initiates	$3	+175.23%	Apr 14, 2026
Frank Takkinen Lake Street	Lake Street	Strong Buy Initiates $4	Strong Buy	Initiates	$4	+266.97%	Dec 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

2.47M

EPS This Year

-0.97

from -1.51

EPS Next Year

-1.08

from -0.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	270.00K	189.00K	300.00K	602.00K	-	-	2.47M
Revenue Growth	-	-30.00%	58.73%	100.67%	-	-	-
EPS	-27.15	-31.50	-48.16	-11.22	-1.51	-0.97	-1.08
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	3.2M
Avg	n/a	2.5M
Low	n/a	1.8M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.00	-1.11
Avg	-0.97	-1.08
Low	-0.93	-1.04

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.